|
Mumbai, Oct 31 (PTI) Aurobindo Pharma Ltd today said it had got marketing authorization from United Kingdom Medicines and Healthcare products Regulatory Agency (UK MHRA) for anti-depression drug Sertraline.
Publication: PTI - The Press Trust of India Ltd. Publication Date: 31-OCT-05 |
|
|
|
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
|
|
|
COPYRIGHT 2005 Asia Pulse Pty Ltd
The authorisation is for strengths of 50 mg and 100 mg tablets of Sertraline, the company informed Bombay Stock Exchange.
Sertraline contains the active ingredient Sertraline Hydrochloride and is the first approval received by the company from UK MHRA for a product developed in-house, it said.
With this approval,...
Read the full article for free courtesy of your local library.
|
|
|
|
 |
| More Articles from PTI - The Press Trust of India Ltd. |
New Delhi, Oct 31 (PTI) Going a step ahead of Tata Teleservice, IDEA C...
October 31, 2005
|
New Delhi, Oct 31 (PTI) Mankind Pharma today said it will donate Rs 2 ...
October 31, 2005
|
Bangalore, Oct 31 (PTI): Commodities and vegetable market remained clo...
October 31, 2005
|
Jaipur, Oct 31 (PTI) ONGC and Rajasthan State Power Generation Corpora...
October 31, 2005
|
Dubai, Oct 31 (PTI) Forced to work without payment for allegedly over ...
October 31, 2005
|
|
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
